Drug intelligence / Profile preview

SGY-101

Development stage: Preclinical
Lead developer: Sagesse Bio
Modality: Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration: Subcutaneous, Intralesional

Overview

SGY-101 is a novel small interfering RNA (siRNA) therapeutic being developed for aesthetic medicine, specifically targeting focal fat reduction and tissue remodeling. The drug is designed as an RNA interference (RNAi)-based product to modulate gene expression in adipose tissue, aiming to reduce localized fat deposits and remodel tissue structure. SGY-101 is being advanced by Sagesse Bio, with support from Sirnaomics and Gore Range Capital. The product leverages proprietary delivery technologies for targeted action in subcutaneous tissues. As of the latest updates, it has reached preclinical development with plans for rapid clinical advancement in body contouring and medical dermatology applications[1][3][4][7].

Beyond the preview

Go deeper on SGY-101.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SGY-101.

Explore the full profile